These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32538831)

  • 1. Herd immunity or suppression strategy to combat COVID-19.
    Jung F; Krieger V; Hufert FT; Küpper JH
    Clin Hemorheol Microcirc; 2020; 75(1):13-17. PubMed ID: 32538831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How we should respond to the Coronavirus SARS-CoV-2 outbreak: A German perspective.
    Jung F; Krieger V; Hufert FT; Küpper JH
    Clin Hemorheol Microcirc; 2020; 74(4):363-372. PubMed ID: 32390611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
    Laxminarayan R; John TJ
    Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
    [No Abstract]   [Full Text] [Related]  

  • 4. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
    J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
    [No Abstract]   [Full Text] [Related]  

  • 5. Herd immunity and COVID-19.
    Chen J; Ye L; Zhou MY; Cheng YR; Wang MW; Feng ZH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4064-4065. PubMed ID: 32374011
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19: Mitigation or suppression?
    Kassem AM
    Arab J Gastroenterol; 2020 Mar; 21(1):1-2. PubMed ID: 32331618
    [No Abstract]   [Full Text] [Related]  

  • 7. An emergency strategy for intensive care unit during COVID-19 outbreak in Chongqing, China.
    Deng W; Qi D; Wang DX
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7886-7888. PubMed ID: 32744717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19: Human challenge studies will see people purposefully infected with virus.
    Mahase E
    BMJ; 2020 Oct; 371():m4101. PubMed ID: 33093016
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
    Papachristodoulou E; Kakoullis L; Parperis K; Panos G
    Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32510562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathogenesis of COVID-19: Summary and Possible Interventions.
    Jacques FH; Apedaile E
    Front Immunol; 2020; 11():564925. PubMed ID: 33072103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Care Strategies and Trends in Taiwan During the COVID-19 Pandemic].
    Huang YC; Chia SL
    Hu Li Za Zhi; 2020 Dec; 67(6):6-11. PubMed ID: 33274420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
    Zayed H
    Front Immunol; 2020; 11():2051. PubMed ID: 32922408
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 16. The Outcome and Implications of Public Precautionary Measures in Taiwan-Declining Respiratory Disease Cases in the COVID-19 Pandemic.
    Hsieh CC; Lin CH; Wang WYC; Pauleen DJ; Chen JV
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32640752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.
    Lu X; Xiang Y; Du H; Wing-Kin Wong G
    Pediatr Allergy Immunol; 2020 Jul; 31(5):449-453. PubMed ID: 32330332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide.
    Liu NN; Tan JC; Li J; Li S; Cai Y; Wang H
    Curr Cancer Drug Targets; 2020; 20(6):410-416. PubMed ID: 32286947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Immunity Passport to Ease Travel Restrictions?
    Chen LH; Freedman DO; Visser LG
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32463093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.